Page last updated: 2024-09-03

furamidine and Cancer of Lung

furamidine has been researched along with Cancer of Lung in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chepanova, AA; Kaledin, VI; Lavrik, OI; Leung, E; Leung, IKH; Luzina, OA; Nikolin, VP; Patel, J; Popova, NA; Reynisson, J; Salakhutdinov, NF; Sokolov, DN; Volcho, KP; Zafar, A; Zakharenko, AL; Zakharova, OD	1

Other Studies

1 other study(ies) available for furamidine and Cancer of Lung

Article	Year
Novel tyrosyl-DNA phosphodiesterase 1 inhibitors enhance the therapeutic impact of topoteсan on in vivo tumor models. European journal of medicinal chemistry, 2019, Jan-01, Volume: 161 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Lung Neoplasms; Mice; Mice, Inbred C57BL; Models, Molecular; Molecular Structure; Neoplasms, Experimental; Phosphoric Diester Hydrolases; Quantum Theory; Structure-Activity Relationship; Topoisomerase I Inhibitors; Topotecan	2019

Article

Year

Novel tyrosyl-DNA phosphodiesterase 1 inhibitors enhance the therapeutic impact of topoteсan on in vivo tumor models.

European journal of medicinal chemistry, 2019, Jan-01, Volume: 161

Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Lung Neoplasms; Mice; Mice, Inbred C57BL; Models, Molecular; Molecular Structure; Neoplasms, Experimental; Phosphoric Diester Hydrolases; Quantum Theory; Structure-Activity Relationship; Topoisomerase I Inhibitors; Topotecan

2019